针对急性心力衰竭的早期动员:范围和系统性审查
Masatsugu Okamura1, Yuki Kataoka2, Shunsuke Taito3
1Berlin Institute of Health Center for Regenerative Therapies (BCRT), Charité - Universitätsmedizin Berlin, Berlin, Germany; Department of Rehabilitation Medicine, School of Medicine, Yokohama City University, Yokohama, Japan; Scientific Research WorkS Peer Support Group (SRWS-PSG), Osaka, Japan.
Journal of cardiology
|October 5, 2023
概括
早期动员,定义为干预或在急性心力衰竭 (HF) 住院后3天内行走,可能会降低再入院率. 需要进一步的研究来证实这一关联.
科学领域:
- 心脏病学 心脏病学
- 康复医学 康复医学 康复医学
- 基于证据的实践.
背景情况:
- 对于住院患者来说,早期动员越来越被认可.
- 它在急性心力衰竭 (HF) 中的应用缺乏明确的定义,有效性和安全性数据.
- 对于急性HF患者的现有临床实践需要建立早期动员的协议.
研究的目的:
- 在急性心力衰竭的背景下,定义"早期动员".
- 系统地审查和对急性HF早期动员的有效性和安全性进行元分析.
- 为临床实践提供基于证据的建议.
主要方法:
- 范围审查 (第一部分) 确定了早期动员的定义.
- 一项系统性审查和元分析 (第二部分) 评估了有效性和安全性.
- 搜索内容包括MEDLINE,Cochrane,Embase,CINAHL和PEDro. 这三家公司的搜索.
主要成果:
- 早期动员被定义为基于协议的干预措施或在入院后3天内行走.
- 两个观察性研究 (283名参与者) 被纳入了元分析.
- 早期动员显示,在低确定性证据的情况下,再接收率可能大幅降低 (OR 0.25,95% CI 0.14-0.42).
结论:
- 早期动员,定义为干预或在入院后3天内行走,可能与急性HF的再入院率较低有关.
- 由于研究细节有限,早期动员的频率,强度和数量仍未确定.
- 进一步的研究对于建立因果关系和优化急性HF早期动员策略至关重要.
相关概念视频
Heart Failure V: Medical Management
10
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
10
Heart Failure IV: Classification and Diagnostic Evaluation
19
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
19
Heart Failure VII: Nursing Interventions
86
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
86
Heart Failure II: Pathophysiology
14
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
14
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16


